CIK: 0001637359
Total reported value
$163.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Translate Bio INC | Stock-Other | 22.75% | — | — | |
| 2 | PRTKEUR | Paratek Pharmaceuticals INC | Stock-Other | 19.57% | — | — | |
| 3 | ✓ | Obseva SA | Stock-Other | 11.17% | — | -0.03% | |
| 4 | ✓ | Stock-Other | 8.85% | — | — | ||
| 5 | SNNAQ | Sienna Biopharmaceuticals In | Stock-Other | 8.50% | — | — | |
| 6 | FGENEUR | Fibrogen INC | Stock-Other | 6.03% | — | — | |
| 7 | ✓ | Cidara Therapeutics INC Com New | Stock-Other | 5.79% | — | +239.08% | |
| 8 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 5.46% | — | — | |
| 9 | ✓ | Essa Pharma INC | Stock-Other | 3.04% | — | -95.00% | |
| 10 | JNCEEUR | Jounce Therapeutics INC | Stock-Other | 3.00% | — | — | |
| 11 | PIRSEUR | Pieris Pharmaceuticals INC | Stock-Other | 2.91% | — | — | |
| 12 | DRNAUSD | Dicerna Pharmaceuticals INC | Stock-Other | 2.02% | — | — | |
| 13 | EGLTEUR | Egalet CORP | Stock-Other | 0.90% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Cidara Therapeutics INC Com New | +4% | +239.08% | Add |
| 2 | FGENEUR | Fibrogen INC | +0.1% | — | Unchanged |
| 3 | DRNAUSD | Dicerna Pharmaceuticals INC | -0.1% | — | Unchanged |
| 4 | EGLTEUR | Egalet CORP | -0.9% | — | Unchanged |
| 5 | ✓ | Essa Pharma INC | -1% | -95.00% | Trim |
| 6 | CBAYUSD | Cymabay Therapeutics INC | -1.6% | — | Unchanged |
| 7 | ✓ | Obseva SA | -2.1% | -0.03% | Trim |
| 8 | PIRSEUR | Pieris Pharmaceuticals INC | -2.3% | — | Unchanged |
| 9 | SNNAQ | Sienna Biopharmaceuticals In | -5.5% | — | Unchanged |
| 10 | JNCEEUR | Jounce Therapeutics INC | -8.6% | — | Unchanged |
| 11 | PRTKEUR | Paratek Pharmaceuticals INC | -13.7% | — | Unchanged |
| 12 | ✓ | Translate Bio INC | — | NEW | New buy |
| 13 | ✓ | — | NEW | New buy | |
| 14 | ✓ | Juno Therapeutics | — | — | Unchanged |